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Summary The quality of cancer registry data is of great importance to the usefulness of a cancer registry. To
investigate the quality of its data the IKL cancer registry (Integraal Kankercentrum Limburg) performed a
study with the aim of comparing data supplied by clinicians with data collected by registration personnel.
Twenty clinicians reabstracted the information of a random sample of about ten of their patients, who were
diagnosed with cancer in 1989 or 1990. After coding, the information was compared with the contents of the
cancer registry records.
For comparison of agreement the information of 190 cases was available. The relative frequency of major
disagreements was 0% for date of birth, 0% for gender, 5% for date of incidence, 6% for primary site, 2% for
laterality, 2% for histologic type and 2% for behaviour code.
In general, the disagreements could be attributed to the handling of different coding rules (incidence date),
or to a lower level of precision by the clinician in comparison to registration personnel (primary site,
laterality).
This study has shown that registration personnel are able to collect data with a high degree of accuracy.
Cancer registries differ noticeably in the way data are col-
lected. The Danish cancer registry receives the data on regist-
ration forms directly from general practitioners, practising
specialists, hospital departments, etc. (Storm, 1991). Other
cancer registries in Great Britain and the United States col-
lect data by specially trained registration personnel. (Skeet,
1991).
When the Netherlands cancer registry started in the early
eighties, the regional cancer registries opted for active data
collection by registration personnel. The willingness of
clinicians to complete cancer registry forms was expected to
be low.
However, the accuracy of registration personnel in collec-
ting the data was questioned by some clinicians. But the
accuracy and the reliability of the data is of vital importance
for the cancer registry, because it is generally accepted that
the usefulness of a cancer registry depends largely on the
quality of its data (Robles et al., 1988). To investigate this
quality the IKL cancer registry performed a study in 1991
with the aim of comparing data that are supplied by
clinicians with data collected by registration personnel.
Methods
The IKL cancer registry
The IKL cancer registry (IKL = 'Integraal Kankercentrum
Limburg' or 'Comprehensive Cancer Centre Limburg') was
established in 1984 and is located in Maastricht. From 1986
onwards, all nine hospitals and seven pathology laboratories
in the Limburg region were participating in the registry.
Recently, incidence data for the period 1986-1988 have been
published (Schouten et al., 1992a; Schouten et al., 1992b).
The cancer registry receives lists of newly diagnosed cases on
a regular basis from the seven pathology departments in the
region. In addition, lists of hospitalised cancer patients are
obtained from the medical record departments of the nine
hospitals and the Radiotherapeutic Institute. Following this
notification, the medical records of newly diagnosed patients
(and tumours) are collected and the relevant information for
the cancer registry is abstracted in the hospital from the
medical records by trained registration personnel of the IKL
cancer registry (Schouten et al., 1992a). Topography and
morphology are coded according to ICD-Oncology (ICD-O,
1976). Data that are entered into the database are extensively
checked for possible errors, inconsistencies and duplicate
records.
Study design
Twenty eight clinicians were chosen from the clinicians that
participate in the activities of the comprehensive cancer cen-
tre. Of them, twenty agreed to participate in the study. Their
distribution, according to specialism and hospital, was
representative for the clinicians in the IKL area. From the
cancer registry database of each clinician about ten patients
diagnosed in 1989 or 1990 were selected at random.
The clinician was asked to fill in a cancer registry form,
that was developed especially for this study, for each of his
patients. The form was accompanied by a comprehensive
explanation. The collected items were date of birth, gender,
date of incidence, primary site (to be completed in free text),
laterality, histologic type (free text) and behaviour code (in
free text).
The returned forms were coded by one of the senior staff
members of the cancer registry. The coded forms were
returned to the clinician and only after approval were the
codes compared with the original information in the cancer
registry. Differences were divided into minor and major
disagreements according to an adapted proposal from a
reabstracting study (CCPDS, 1985) and are summarised in
Table I. For histologic type the ICD-O codes were merged
into clinically and epidemiologically relevant groups (Berg,
1982).
Results
The twenty clinicians completed 190 cancer registry forms.
For one clinician only eight eligible patients (instead of ten)
could be selected. Two of the clinicians returned only 12 out
of 24 forms in time. All the coded information of the forms
was approved by the clinicians. In Table II the results of the
comparison of the clinicians' data with the original cancer
registry data are presented.
No disagreements were detected in date of birth and
gender. With respect to data of incidence ten cases (5%)
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Table I Definition of minor and major disagreements
Item Codes Minor disagreement Major disagreement
Date of birth any difference
Gender any difference
Date of incidence <one month >one month
Primary site ICD-0 - difference in the fourth digit difference in first three digits
- difference in the fourth digit
if 154.0-1 vs 154.2-3
example different lobes of the lung lung vs larynx
Laterality - other differences - right vs left
example right vs unknown
Histologic type ICD-0 other differences in the difference in major groupsa
first three digits
example carcinoma vs squamous cell carc.
squam. cell. carc. vs adenocarc.
Behaviour code ICD-0 0-2 vs 3-9
example in situ vs invasive
aAccording to Berg (1982) the histology was merged into ten groups, i.e. epidermoid carcinoma,
adenocarcinoma, other specific carcinoma, unspecified carcinoma, lymphomas, sarcomas and other soft tissue
tumours, other specified (and site-specific) types of cancer, unspecified types of cancer and leukaemias.
Table II Results of the comparison of the data supplied by
clinicians with those by registration personnel
Number In exact Minor dis- Major dis-
of cases agreement agreement agreement
Items N N (%) N (%) N (%)
Date of birth 190 190 (100) -a ( 0) 0 (0)
Gender 190 190 (100) -a (_) 0 (0)
Date of incidence 190 102 (54) 78 (41) 10 (5)
Primary site 190 151 (79) 28 (15) 11 (6)
Laterality 105 92 (88) 11 (10) 2 (2)
Histologic type 190 163 (86) 23 (12) 4 (2)
Behaviour code 190 187 (98) -a (-) 3 (2)
aFor this item a minor disagreement was not defined.
contained major and 78 cases (41%) contained minor
differences. The majority of these differences can be att-
ributed to the use of other coding rules by the clinician. For
example, the clinician often considers the date of first consul-
tation as date of incidence, whilst the cancer registry uses the
date of first microscopic confirmation.
Comparison of the primary tumour site revealed 11 major
(6%) and 28 minor (15%) disagreements between clinician
and registration personnel (see Tables II and III). The
majority of the disagreements (nine out of 11) are related to
the malignancies of the rectosigmoid juntion or primary un-
known site. With respect to the rectosigmoid junction it
turned out that the clinician in two out of three cases agreed
with the registry coding after reviewing the files.
With respect to the item laterality two major differences
were found. In one case the clinician had made a coding error,
and in the other case the information could not be verified.
For histologic type only four major differences (2%) were
detected. In Table III the major differences are listed. Three
of the disagreements could be attributed to coding errors of
registration personnel. The majority of the minor differences
(15 from 23) was coded more specificially by the cancer
registry (e.g. papillary adenocarcinoma opposed to adenocar-
cinoma). In five other minor differences the clinician used the
more specific description of the histology.
Three times (2%) there was a major disagreement in the
behaviour code. Once registration personnel had incorrectly
coded 'malignant' instead of 'borderline' (a refractory anemia
with excess blasts was coded as leukaemia). Therefore, this
tumour was wrongly included in the database, because
borderline tumours should not be registered.
In total, 161 cases (85%) were in agreement for all inves-
tigated items or had only minor disagreements; 28 cases
(15%) had one major disagreement and one case (0.5%) had
two major disagreements.
In Table IV the percentages of major disagreements for
date of incidence, primary site and histologic type and the
percentage of records with a major disagreement were shown
according to groups of tumour sites. The percentages of
major disagreements are the highest for lymphatic and
haematological malignancies and malignancies with an un-
known primary site.
Discussion
In 29 out of 190 cases (= 15%) we found one or more major
disagreement between the information recorded by the
clinician and the cancer registry. Most disagreements were
observed for the item primary site (N = 11). Of these, five
were coded by IKL as primary unknown. In only four out of
the nine original cases did the clinician agree with the topo-
graphic diagnosis 'primary site unknown'. We suppose that
the clinicians handled different rules for defining primary
unknown malignancies. It is also possible that the primary
site of the neoplasm had become clear some time after the
abstracting and coding of a case by registration personnel
(which happens 3-6 months after diagnosis).
The high frequency of disagreement with respect to the
malignancies with primary unknown site is notable, also in
view of the high incidence rates of this entity for males for
the IKL cancer registry in comparison with other registries
(Parkin et al., 1992). In contrast, the incidence rates of this
entity in females are comparable with other cancer registries
(Schouten et al., 1992a).
Another frequent disagreement concerned the sigmoid
colon and rectosigmoid junction. It is our experience that the
different responsible clinicians often disagree over the same
patient with respect to this topographical diagnosis in the
reports. The differences in treatment and prognosis of sig-
moid and rectosigmoid cancer are not substantial. For a
clinician this difference in topography is therefore unimpor-
tant.
For histologic type, the number of major disagreements
was small. Two of the disagreements would probably have
been reported by computer software developed to trace
inconsistencies. At the moment of the study, such a program
had not yet been used for this part of the database.
Although the percentage of major disagreements for
behaviour code was low (2%), it will cause bias. The distinc-
tion between invasive and non-invasive is often decisive for
inclusion in incidence statistics, which are often limited to
invasive malignancies only. The differences in this study con-
cerned cases of a refractory anemia (coded as leukaemia),
invasive breast cancer (coded as non-invasive) and a non-
infiltrating papillary bladder cancer (coded as invasive). The
prevention of these errors asks for more attention in the
training of the registration personnel.
Recently, a comparable study of the quality of registry
data has been published (Lapham & Waugh, 1992). This976 L.J. SCHOUTEN et al.
Table III Major disagreements for primary site and histologic type
Clinician Cancer Registry No of
ICD-0 Description ICD-0 Description cases
Topography
143.9 Gum, NOS 145.9 Oral cavity, NOS 1
154.0 Rectosigmoid junction 153.3 Sigmoid 1
153.3 Sigmoid 154.0 Rectosigmoid junction 2
158.0 Peritoneum, NOS 183.0 Ovary 1
199.9 Primary site unknown 183.0 Ovary 1
153.8 Colon, other 199.9 Primary site unknwon 1
162.9 Lung, NOS 199.9 Primary site unknown 2
174.9 Breast, NOS 199.9 Primary site unknown 1
194.0 Suprarenal gland 199.9 Primary site unknown 1
Histologic type
9593 Large cell non-Hodgkin
lymphoma 8070 Squamous cell carc. 1
8230 Solid carcinoma 8240 Carcinoid 1
8030 Giant cell and spindle
cell carcinoma 8830 Leiomyosarcoma 1
9823 Chron. Lymph. leukaemia 9671 Immunocytoma 1
Table IV Total cases abstracted by tumour site, and number of records (% of total abstracted) with major disagreements in
the date of incidence, the primary site, the histological type and other items
Records with major disagreements
Total number Date of Primary Histologic Other
of cases Totala incidence site type items"
ICD-O N N (%) N (%) N (%) N (%) N (%)
140-149, 160-161 Mouth, pharynx and larynx 12 4 (33) 2 (17) 1 (8) 1 (8) 0 (0)
150-159 Gastro-intestinal tract 33 6 (18) 3 (9) 3 (9) 0 (0) 0 (0)
162-165 Lung and mediastinum 32 1 (3) 0 (0) 0 (0) 0 (0) 1 (3)
173 Skin 11 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
174-175 Breast 29 3 (10) 1 (3) 0 (0) 1 (3) 1 (3)
179-184 Female genital organs 21 2 (10) 0 (0) 2 (10) 0 (0) 0 (0)
185-187 Male genital organs 15 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
188-189 Urinary tract 16 4 (25) 3 (19) 0 (0) 0 (0) 1 (6)
169, 196 Lymphatic/haematopoetic 8 3 (37) 0 (0) 0 (0) 1 (13) 2 (25)
199 Primary tumour unknown 9 5 (56) 1 (11) 5 (56) 0 (0) 0 (0)
other Other 4 1 (25) 0 (0) 0 (0) 1 (25) 0 (0)
140-199 Total 190 29 (15) 10 (5) 11 (6) 4 (2) 5 (3)
'Records with one or more major disagreement in the items. Because some records have more than one major disagreement
the total of the row can be higher than the stated total in this column. bDate of birth, gender, laterality and behaviour code.
study focused on disagreements in primary site. The number
of major disagreements (11 out of 200 cases) was quite
similar to our study, despite the use of other criteria.
Lapham and Waugh reported a considerable number of
disagreement with respect to malignant lymphomas. They
attributed this to the fact that the lymphoma chapter of the
ICD-9 has become outdated. In our study the malignant
lymphomas were not especially prone to disagreements with
respect to histologic type. We ascribe this to the fact that the
Netherlands Cancer Registry uses the ICD-0 and has
developed special codes for the histology of malignant lym-
phomas (Otter, 1989).
The quality of cancer registry data has received increasing
attention in recent years, but only relatively few studies on
this issue have been published. Those studies are in general
focused on 'completeness' or 'accuracy' (Hilsenbeck, 1990).
The studies on accuracy are, in fact, reproducibility studies.
In this study we compared data from the source (the
clinicians) with the data as abstracted and coded by registra-
tion personnel. The data from the clinicians cannot be used
as a golden standard, because clinicians and registration
personnel collect data with a different perspective. Whereas
clinicians use their data for making the decisions on treat-
ment and prognosis, registration personnel are trained to
accomplish uniformity with the help of strict coding rules.
Some clinicians did supply information with less than
required detail, because the more detailed information was
not directly relevent for their daily clinical practice.
Another possible reason for differences in information are
differences in knowledge of the medical background of the
patient. Registration personnel have to rely on the inform-
ation in the clinical files, which is sometimes not fully com-
plete. The clinician has more direct information on the
patient and his disease, but has less knowledge of the coding
rules of the cancer registry. In general, the information sup-
plied by clinicians does agree rather well with the inform-
ation abstracted and coded by registration personnel.
It can therefore be concluded that registration personnel,
as trained and supported in the Netherlands cancer registries,
are capable of collecting data for the cancer registry with a
high degree of accuracy and reliability. However, coding
rules for unknown primary malignancies ought to be im-
proved and in some aspects the registration personnel need
more training.
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